Empirically supported substance abuse treatment approaches: a survey of treatment providers' perspectives and practices.

Addictive Behaviors
Diane M HerbeckCheryl Teruya

Abstract

To better understand the extent that empirically supported and promising substance abuse treatment approaches are implemented in community settings, treatment providers were surveyed regarding their perceptions and use of several psychosocial and pharmacological treatment interventions. Program directors (n=30) and staff members (n=331) from diverse community settings rated the effectiveness and extent of use of various treatment interventions, and provided information on program and workforce characteristics via self-administered questionnaires. On average, program directors and staff rated the psychosocial treatment interventions as effective, with the exception of vouchers/motivational incentives. About half of the treatment providers did not know the effectiveness of certain pharmacological treatments, including buprenorphine and naltrexone. Respondents from the majority of programs (55%-80%) reported using Motivational Enhancement Therapy, Community Reinforcement Approach, and Supportive Expressive Psychotherapy. The extent that programs used several of the treatment interventions was related to organizational training and information resources. The study findings provide important information regarding training and resear...Continue Reading

References

Jan 10, 2001·Annual Review of Psychology·D L Chambless, T H Ollendick
Apr 17, 2001·Archives of Psychiatric Nursing·B F Hagen, D L Mitchell
Aug 23, 2001·Journal of Substance Abuse Treatment·R F FormanG Woody
Nov 10, 2001·American Journal of Preventive Medicine·B BorrelliD B Abrams
Jun 20, 2002·Journal of Substance Abuse Treatment·Wayne E K LehmanD Dwayne Simpson
Mar 1, 2003·Psychiatric Services : a Journal of the American Psychiatric Association·Peter P Roy-ByrneAlexander Bystritsky
Dec 19, 2003·Journal of Substance Abuse Treatment·A Thomas McLellanHerbert D Kleber
Jan 9, 2004·The Psychiatric Clinics of North America·Mark P McGovern, Kathleen M Carroll
Feb 28, 2004·Journal of Psychoactive Drugs·Hannah K KnudsenCarrie B Oser
Nov 24, 2004·Biological Psychiatry·A Thomas McLellan, Kathleen Meyers
Dec 14, 2004·Administration and Policy in Mental Health·Michael A HogeMaria J O'Connell
Apr 29, 2005·Journal of Substance Abuse Treatment·Jeanne L ObertAhndrea Weiner
Apr 29, 2005·Journal of Substance Abuse Treatment·Bret E FullerHelen Levine
May 6, 2005·Psychiatric Services : a Journal of the American Psychiatric Association·Greer SullivanKathy Henderson
Aug 2, 2005·The American Journal of Psychiatry·Frank J VocciAhmed Elkashef
Nov 29, 2005·Journal of Substance Abuse Treatment·William R MillerWendy R Johnson
Nov 29, 2005·Journal of Substance Abuse Treatment·Scott T WaltersDouglas M Ziedonis

❮ Previous
Next ❯

Citations

Dec 22, 2011·Journal of Psychoactive Drugs·Traci RieckmannCaitlin Rasplica
Aug 6, 2010·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Brian E BridePaul M Roman
Oct 19, 2013·Journal of Addictions Nursing·Hannah K Knudsen, Amanda J Abraham
Dec 20, 2012·Journal of Medical Internet Research·Melissa M NorbergPeter J Gates
Jan 28, 2014·Journal of Substance Abuse Treatment·Bryan HartzlerDonald A Calsyn
Oct 23, 2012·Journal of Substance Abuse Treatment·Cynthia RoweOlivier Phan
Jan 3, 2012·Journal of Substance Abuse Treatment·Amy MurphyFaye S Taxman
Dec 6, 2011·Journal of Substance Abuse Treatment·Bryan HartzlerDennis McCarty
Nov 26, 2011·Journal of Substance Abuse Treatment·Kimberly C KirbyRobert C Sterling
Jun 19, 2010·Health Policy·Suzette Glasner-Edwards, Richard Rawson
Oct 2, 2009·Peptides·Richard J Bodnar
Oct 5, 2010·International Journal of Mental Health Nursing·Thomas E WoodVijayan K Pillai
Oct 21, 2010·The American Journal on Addictions·Lori J DucharmePaul M Roman
Dec 4, 2014·Health & Social Care in the Community·Christine TimkoRudolf H Moos
Aug 23, 2011·The American Journal of Drug and Alcohol Abuse·Shelly F GreenfieldTheresa Winhusen
Jul 8, 2015·Evaluation and Program Planning·Angela RobertsonLee McCluskey
Jan 20, 2009·Evaluation and Program Planning·Elizabeth EvansYih-Ing Hser
Jun 27, 2014·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Melinda D'IppolitoDeborah Chassler
Mar 5, 2014·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Bryan Hartzler, Carl Rabun
Oct 31, 2014·Stroke; a Journal of Cerebral Circulation·James F MeschiaUNKNOWN Council on Hypertension
Dec 4, 2010·Stroke; a Journal of Cerebral Circulation·Larry B GoldsteinUNKNOWN Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research
Sep 11, 2012·Substance Abuse Treatment, Prevention, and Policy·Christine TimkoRuth C Cronkite
Jun 17, 2020·The American Journal of Drug and Alcohol Abuse·Barbara Andraka-ChristouJason Ford
Apr 1, 2009·Behavior Analysis in Practice·John M RollNancy M Petry
Sep 11, 2018·Journal of Community Psychology·James L Sorensen, Jasmin D Llamas
Apr 3, 2021·Frontiers in Psychology·Ingmar GormanJonathan Sabbagh
Sep 15, 2021·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Aaron R Brown

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.